| Enriched cancer pathway | Genes under regulation | P value |
|---|
| B cell receptor signaling pathway |
4 genes: AKT3, FOS, PPP3CA, PPP3CC
|
0.001182 |
| Axon guidance |
5 genes: SEMA3C, NTNG1, PPP3CA, PPP3CC, RGS3
|
0.001258 |
| T cell receptor signaling pathway |
4 genes: AKT3, FOS, PPP3CA, PPP3CC
|
0.004463 |
| Osteoclast differentiation |
4 genes: AKT3, FOS, PPP3CA, PPP3CC
|
0.008091 |
| Tight junction |
4 genes: AKT3, PPP2R2C, TJP1, ACTN1
|
0.00923 |
| Adherens junction |
3 genes: CTNND1, TJP1, ACTN1
|
0.01033 |
| Ubiquitin mediated proteolysis |
4 genes: UBE2E2, UBE2H, HERC1, KLHL13
|
0.01073 |
| VEGF signaling pathway |
3 genes: AKT3, PPP3CA, PPP3CC
|
0.01152 |
| Apoptosis |
3 genes: AKT3, PPP3CA, PPP3CC
|
0.01757 |
| Calcium signaling pathway |
4 genes: ADCY2, PPP3CA, PPP3CC, SLC8A2
|
0.02387 |
| MAPK signaling pathway |
5 genes: AKT3, FGF9, FOS, PPP3CA, PPP3CC
|
0.02508 |
| Oocyte meiosis |
3 genes: ADCY2, PPP3CA, PPP3CC
|
0.03334 |
| Leukocyte transendothelial migration |
3 genes: CDH5, CTNND1, ACTN1
|
0.03559 |
| Hedgehog signaling pathway |
2 genes: CSNK1A1, GLI2
|
0.04658 |